A comparison of paroxetine, imipramine and placebo in depressed out-patients. 1991

G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
CNS Therapeutic Unit, Clinical Research and Development, SmithKline Beecham Pharmaceuticals, Long Beach.

To compare the safety and antidepressant efficacy of paroxetine, imipramine, and placebo, data from six centres using the same protocol were pooled. A double-blind parallel-group design was used, with therapy lasting six weeks. From week 2 onwards, both the 240 paroxetine-treated and the 237 imipramine-treated patients were significantly different from the 240 placebo-treated patients, but no different from each other. Side-effects with paroxetine were less likely to lead to drop-out than with imipramine. Paroxetine had a possible earlier antidepressant effect than imipramine, and a possible earlier beneficial effect on anxiety symptoms associated with depression.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010556 Personality Tests Standardized objective tests designed to facilitate the evaluation of personality. Personality Test,Test, Personality,Tests, Personality
D010880 Piperidines A family of hexahydropyridines.
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
June 1992, International clinical psychopharmacology,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
December 1992, The Journal of clinical psychiatry,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
May 1993, Acta psychiatrica Scandinavica,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
December 1984, Journal of affective disorders,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
February 1992, The Journal of clinical psychiatry,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
October 1964, The Journal of nervous and mental disease,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
June 1996, International clinical psychopharmacology,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
June 1997, Journal of affective disorders,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
March 1998, The American journal of psychiatry,
G C Dunbar, and J B Cohn, and L F Fabre, and J P Feighner, and R R Fieve, and J Mendels, and R K Shrivastava
February 1992, The Journal of clinical psychiatry,
Copied contents to your clipboard!